2022 Year in Review – Mast Cell Tumors – are we entering a paradigm shift

The last two years have witnessed a number of significant events in the world. In the world of canine Mast Cell Tumor (MCT) research, the same can be said. Recent evidence has brought into question conventional diagnostic and treatment approaches to MCT cases. This new data is changing the way Oncologists, Surgeons and other specialists at major institutions are managing these cases.